| PD-L1 binds to B7-1 only in cis on the same cell surface A Chaudhri, Y Xiao, AN Klee, X Wang, B Zhu, GJ Freeman Cancer immunology research 6 (8), 921-929, 2018 | 173 | 2018 |
| A secreted PD-L1 splice variant that covalently dimerizes and mediates immunosuppression KM Mahoney, SA Shukla, N Patsoukis, A Chaudhri, EP Browne, A Arazi, ... Cancer Immunology, Immunotherapy 68, 421-432, 2019 | 128 | 2019 |
| Emerging concepts in PD-1 checkpoint biology KE Pauken, JA Torchia, A Chaudhri, AH Sharpe, GJ Freeman Seminars in immunology 52, 101480, 2021 | 122 | 2021 |
| Interaction of SHP-2 SH2 domains with PD-1 ITSM induces PD-1 dimerization and SHP-2 activation N Patsoukis, JS Duke-Cohan, A Chaudhri, HI Aksoylar, Q Wang, ... Communications biology 3 (1), 128, 2020 | 118 | 2020 |
| Cytotoxicity of TiO2 nanoparticles and their detoxification in a freshwater system S Dalai, S Pakrashi, MJ Nirmala, A Chaudhri, N Chandrasekaran, ... Aquatic Toxicology 138, 1-11, 2013 | 95 | 2013 |
| Microbially derived pectinases: a review A Chaudhri, V Suneetha IOSR J Pharm Biol Sci 2 (2), 1-5, 2012 | 54 | 2012 |
| 31st annual meeting and associated programs of the society for immunotherapy of cancer (Sitc 2016): Part two: National harbor, md, USA. 9-13 November 2016 C Ager, M Reilley, C Nicholas, T Bartkowiak, A Jaiswal, M Curran, ... Journal for ImmunoTherapy of Cancer 4, 107-221, 2016 | 21* | 2016 |
| Screening and Identification of degradable products by pectin lyase producing Actinomycetes from katpadi and chittoor fruit industrial waste enriched soil samples RK V Suneetha, M Bishwambhar, R Gopinath, SR Shrestha, Gaurav KB Kartik, C ... Asian Journal of Microbiology, Biotechnology & Environmental Sciences Paper …, 2012 | 16* | 2012 |
| PD-L1 binds to B7-1 only in cis on the same cell surface. Cancer Immunol. Res. 2018; 6: 921–929. doi: 10.1158/2326-6066 A Chaudhri, Y Xiao, AN Klee, X Wang, B Zhu, GJ Freeman CIR-17-0316.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 15 | |
| Microbial Derived Pectinases: A Review C Apoorvi, S Vuppu IOSR Journal of Pharmaceutical and Biological Sciences, 2 (2), 1-5, 2012 | 10 | 2012 |
| PD-L1 Binds to B7-1 Only In Cis on the Same Cell Surface. Cancer Immunol Res 6: 921–929 A Chaudhri, Y Xiao, AN Klee, X Wang, B Zhu, GJ Freeman | 6 | 2018 |
| The B7: CD28 family and friends: Unraveling coinhibitory interactions KP Burke, A Chaudhri, GJ Freeman, AH Sharpe Immunity 57 (2), 223-244, 2024 | 5 | 2024 |
| The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy A Chaudhri, X Bu, Y Wang, M Gomez, JA Torchia, P Hua, SH Hung, ... Frontiers in immunology 14, 1237715, 2023 | 4 | 2023 |
| Enhancer reprogramming in melanoma immune checkpoint therapy resistance M Maitituoheti, A Shi, M Tang, LL Ho, C Terranova, K Galani, EZ Keung, ... bioRxiv, 2022.08. 31.506051, 2022 | 3 | 2022 |
| Chromatin Remodelers Are Regulators of the Tumor Immune Microenvironment A Chaudhri, G Lizee, P Hwu, K Rai Cancer Research 84 (7), 965-976, 2024 | 2 | 2024 |
| IMMU-15. PD-1 BLOCKADE ACTIVATES CD4 T CELLS AND THE INNATE IMMUNE RESPONSE FOR GLIOBLASTOMA ERADICATION SR Klein, MC Speranza, PC Gokhale, MK Wilkens, KL Jones, ... Neuro-Oncology 19 (Suppl 6), vi115, 2017 | 1 | 2017 |
| 808 The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances responses to anti-PD-1 immunotherapy A Chaudhri, X Bu, Y Wang, P Hua, SH Hung, MA Davies, GA Lizee, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| Functional roles of enhancers in immune microenvironment & immunotherapy response K Rai, M Maitituoheti, A Shi, M Tang, LL Ho, FY Kreidieh, C Terranova, ... Cancer Research 83 (7_Supplement), 6425-6425, 2023 | | 2023 |
| The Cx3Cl1-Cx3Cr1 Chemokine Axis Contributes To Tumor Immune Evasion And Its Blockade Enhances Responses To Anti-Pd-1 Immunotherapy A Chaudhri | | 2023 |
| Methods for treating cancer using combinations of anti-cx3cr1 and immune checkpoint blockade agents GJ Freeman, A Chaudhri US Patent App. 17/606,585, 2022 | | 2022 |
